MARKET

RDGL

RDGL

Vivos
OTCMQB
0.059
0.000
0.51%
Closed 15:58 06/30 EDT
OPEN
0.062
PREV CLOSE
0.059
HIGH
0.064
LOW
0.059
VOLUME
489.51K
TURNOVER
30.38K
52 WEEK HIGH
0.155
52 WEEK LOW
0.043
MARKET CAP
29.34M
P/E (TTM)
-7.9200
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDGL last week (0622-0626)?
Weekly Report · 1d ago
Weekly Report: what happened at RDGL last week (0615-0619)?
Weekly Report · 06/22 09:33
Weekly Report: what happened at RDGL last week (0608-0612)?
Weekly Report · 06/15 09:33
Vivos Gets State Of Washington Radioactive Materials License To Manufacture IsoPet
Benzinga · 06/11 12:32
Vivos wins Washington state radioactive materials license for IsoPet manufacturing
PUBT · 06/11 12:31
Weekly Report: what happened at RDGL last week (0601-0605)?
Weekly Report · 06/08 09:31
Vivos submits early feasibility IDE application to FDA for RadioGel device trial
PUBT · 06/05 12:31
VIVOS INC. (OTCQB: RDGL) SUBMITS EARLY FEASIBILITY INVESTIGATIONAL DEVICE EXEMPTION (IDE) APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR RADIOGEL® PRECISION RADIONUCLIDE THERAPY™
Reuters · 06/05 12:30
More
About RDGL
Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.

Webull offers Vivos Inc stock information, including OTCMQB: RDGL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDGL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDGL stock methods without spending real money on the virtual paper trading platform.